Daily Papers

Reasoning-augmented machine learning systems have shown improved performance in various domains, including image generation. However, existing reasoning-based methods for image generation either restrict reasoning to a single modality (image or text) or rely on high-quality reasoning data for fine-tuning. To tackle these limitations, we propose MILR, a test-time method that jointly reasons over image and text in a unified latent vector space. Reasoning in MILR is performed by searching through vector representations of discrete image and text tokens. Practically, this is implemented via the policy gradient method, guided by an image quality critic. We instantiate MILR within the unified multimodal understanding and generation (MUG) framework that natively supports language reasoning before image synthesis and thus facilitates cross-modal reasoning. The intermediate model outputs, which are to be optimized, serve as the unified latent space, enabling MILR to operate entirely at test time. We evaluate MILR on GenEval, T2I-CompBench, and WISE, achieving state-of-the-art results on all benchmarks. Notably, on knowledge-intensive WISE, MILR attains an overall score of 0.63, improving over the baseline by 80%. Our further analysis indicates that joint reasoning in the unified latent space is the key to its strong performance. Moreover, our qualitative studies reveal MILR's non-trivial ability in temporal and cultural reasoning, highlighting the efficacy of our reasoning method.

The emergence of large language models (LLMs) has revolutionized machine learning and related fields, showcasing remarkable abilities in comprehending, generating, and manipulating human language. However, their conventional usage through API-based text prompt submissions imposes certain limitations in terms of context constraints and external source availability. To address these challenges, we propose a novel framework called Reinforced Retrieval Augmented Machine Learning (RRAML). RRAML integrates the reasoning capabilities of LLMs with supporting information retrieved by a purpose-built retriever from a vast user-provided database. By leveraging recent advancements in reinforcement learning, our method effectively addresses several critical challenges. Firstly, it circumvents the need for accessing LLM gradients. Secondly, our method alleviates the burden of retraining LLMs for specific tasks, as it is often impractical or impossible due to restricted access to the model and the computational intensity involved. Additionally we seamlessly link the retriever's task with the reasoner, mitigating hallucinations and reducing irrelevant, and potentially damaging retrieved documents. We believe that the research agenda outlined in this paper has the potential to profoundly impact the field of AI, democratizing access to and utilization of LLMs for a wide range of entities.

Drug discovery is a complex and resource-intensive process, making early prediction of approval outcomes critical for optimizing research investments. While classical machine learning and deep learning methods have shown promise in drug approval prediction, their limited interpretability constraints their impact. Here, we present DrugReasoner, a reasoning-based large language model (LLM) built on the LLaMA architecture and fine-tuned with group relative policy optimization (GRPO) to predict the likelihood of small-molecule approval. DrugReasoner integrates molecular descriptors with comparative reasoning against structurally similar approved and unapproved compounds, generating predictions alongside step-by-step rationales and confidence scores. DrugReasoner achieved robust performance with an AUC of 0.732 and an F1 score of 0.729 on the validation set and 0.725 and 0.718 on the test set, respectively. These results outperformed conventional baselines, including logistic regression, support vector machine, and k-nearest neighbors and had competitive performance relative to XGBoost. On an external independent dataset, DrugReasoner outperformed both baseline and the recently developed ChemAP model, achieving an AUC of 0.728 and an F1-score of 0.774, while maintaining high precision and balanced sensitivity, demonstrating robustness in real-world scenarios. These findings demonstrate that DrugReasoner not only delivers competitive predictive accuracy but also enhances transparency through its reasoning outputs, thereby addressing a key bottleneck in AI-assisted drug discovery. This study highlights the potential of reasoning-augmented LLMs as interpretable and effective tools for pharmaceutical decision-making.

The process of quantifying and analyzing animal behavior involves translating the naturally occurring descriptive language of their actions into machine-readable code. Yet, codifying behavior analysis is often challenging without deep understanding of animal behavior and technical machine learning knowledge. To limit this gap, we introduce AmadeusGPT: a natural language interface that turns natural language descriptions of behaviors into machine-executable code. Large-language models (LLMs) such as GPT3.5 and GPT4 allow for interactive language-based queries that are potentially well suited for making interactive behavior analysis. However, the comprehension capability of these LLMs is limited by the context window size, which prevents it from remembering distant conversations. To overcome the context window limitation, we implement a novel dual-memory mechanism to allow communication between short-term and long-term memory using symbols as context pointers for retrieval and saving. Concretely, users directly use language-based definitions of behavior and our augmented GPT develops code based on the core AmadeusGPT API, which contains machine learning, computer vision, spatio-temporal reasoning, and visualization modules. Users then can interactively refine results, and seamlessly add new behavioral modules as needed. We benchmark AmadeusGPT and show we can produce state-of-the-art performance on the MABE 2022 behavior challenge tasks. Note, an end-user would not need to write any code to achieve this. Thus, collectively AmadeusGPT presents a novel way to merge deep biological knowledge, large-language models, and core computer vision modules into a more naturally intelligent system. Code and demos can be found at: https://github.com/AdaptiveMotorControlLab/AmadeusGPT.

Without relevant human priors, neural networks may learn uninterpretable features. We propose Dynamics of Attention for Focus Transition (DAFT) as a human prior for machine reasoning. DAFT is a novel method that regularizes attention-based reasoning by modelling it as a continuous dynamical system using neural ordinary differential equations. As a proof of concept, we augment a state-of-the-art visual reasoning model with DAFT. Our experiments reveal that applying DAFT yields similar performance to the original model while using fewer reasoning steps, showing that it implicitly learns to skip unnecessary steps. We also propose a new metric, Total Length of Transition (TLT), which represents the effective reasoning step size by quantifying how much a given model's focus drifts while reasoning about a question. We show that adding DAFT results in lower TLT, demonstrating that our method indeed obeys the human prior towards shorter reasoning paths in addition to producing more interpretable attention maps. Our code is available at https://github.com/kakao/DAFT.